摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

potassium bisulfite | 7773-03-7

中文名称
——
中文别名
——
英文名称
potassium bisulfite
英文别名
potassium hydrogen sulfite;potassium bisulphite;potassium;hydrogen sulfite
potassium bisulfite化学式
CAS
7773-03-7
化学式
HO3S*K
mdl
——
分子量
120.17
InChiKey
DJEHXEMURTVAOE-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    decomposes at 190℃ [HAW93]
  • 溶解度:
    不溶于乙醇
  • 物理描述:
    Potassium bisulfite solution is a colorless aqueous with a slight sulfur dioxide odor. Used as a reducing agent and chemical preservative.
  • 颜色/状态:
    White, crystalline powder
  • 气味:
    Sulfur dioxide odor
  • 稳定性/保质期:

    白色结晶粉末,具有较强的还原性。在空气中会被逐渐氧化成硫酸盐。加热至190℃时会分解。它溶于,但不溶于乙醇

计算性质

  • 辛醇/水分配系数(LogP):
    -3.66
  • 重原子数:
    5
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    79.6
  • 氢给体数:
    1
  • 氢受体数:
    4

ADMET

代谢
适量的二氧化硫可以耐受,因为它们会迅速氧化成硫酸盐... /二氧化硫/
FAIRLY LARGE DOSES OF SULFITES CAN BE TOLERATED SINCE THEY ARE RAPIDLY OXIDIZED TO SULFATES... /SULFITES/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 解毒与急救
/SRP:/ 基本治疗:建立专利气道。如有必要,进行吸痰。观察呼吸不足的迹象,如有必要,协助通气。通过非循环呼吸面罩以10至15升/分钟的速度给予氧气。监测肺肿,并在必要时治疗……。预期癫痫发作,并在必要时治疗……。对于眼睛污染,立即用冲洗眼睛。在运输过程中,用生理盐连续冲洗每只眼睛……。不要使用催吐剂。对于摄入,如果患者能吞咽、有强烈的干呕反射且不流口,则用冲洗口腔,并给予5毫升/千克,最多200毫升的进行稀释……。给予活性炭……。在去污染后,用干燥的无菌敷料覆盖皮肤烧伤……。/和相关化合物/
/SRP:/ Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 m1/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Administer activated charcoal ... . Cover skin burns with dry sterile dressings after decontamination ... . /Sulfur and related compounds/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 解毒与急救
/SRP:/ 高级治疗:对于无意识的病人,考虑进行口咽或鼻咽气管插管以控制气道。在上呼吸道阻塞的第一个迹象出现时,可能需要尽早进行插管。监测心率和必要时治疗心律失常...开始静脉输注D5W /SRP: "保持开放",最小流量/。如果出现低血容量的迹象,使用乳酸钠林格液。注意液体过载的迹象。考虑使用药物治疗肺肿...。用安定(Valium)治疗癫痫...。对于伴有低血容量迹象的低血压,谨慎输注液体。如果液体量正常而出现低血压,考虑使用血管加压药。注意液体过载的迹象...。使用丙美卡因化物协助眼部冲洗...。/及其相关化合物/
/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious. Early intubation at the first sign of upper airway obstruction may be necessary. Monitor cardiac rhythm and treat arrhythmias if necessary ... . Start an IV with D5W /SRP: "To keep open", minimal flow rate/. Use lactated Ringer's if signs of hypovolemia are present. Watch for signs of fluid overload. Consider drug therapy for pulmonary edema ... . Treat seizures with diazepam (Valium) ... . For hypotension with signs of hypovolemia, administer fluid cautiously. Consider vasopressors for hypotension with a normal fluid volume. Watch for signs of fluid overload ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Sulfur and related compounds/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 人类毒性摘录
当摄入时,这些溶液通过释放硫酸而引起胃部刺激。/硫酸盐/
WHEN INGESTED, SOLUTIONS CAUSE GASTRIC IRRITATION BY LIBERATION OF SULFUROUS ACID. /SULFITE SALTS/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 人类毒性摘录
...亚硫酸盐在达到大剂量之前都能很好地被耐受;然后会描述出剧烈的绞痛和腹泻、循环系统紊乱、中枢神经系统抑制和死亡。/亚硫酸盐类盐/
...SULFITES ARE WELL TOLERATED UNTIL LARGE DOSES ARE REACHED; THEN VIOLENT COLIC AND DIARRHEA, CIRCULATORY DISTURBANCES, CENTRAL NERVOUS DEPRESSION, & DEATH ARE DESCRIBED. /SULFITE SALTS/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 非人类毒性摘录
硫酸盐气溶胶对小鼠上呼吸道的感官刺激。
SENSORY IRRITATION BY SULFITE AEROSOLS TO UPPER RESP TRACT IN MICE.
来源:Hazardous Substances Data Bank (HSDB)

SDS

SDS:531605776eb7f098b23d95def410bdbf
查看

制备方法与用途

亚硫酸氢钾简介

亚硫酸氢钾是一种无机化合物,主要用于酒精饮料生产过程中的杀菌剂。它已获欧盟批准为食品添加剂(编号:E228)。

鉴别试验

配制(1+5)试样溶液,其钾离子测试呈阳性,亚硫酸氢盐测试也呈阳性。

含量分析

准确称取0.5g样品,按亚硫酸盐定量法用0.1mol/L液50ml反应。放置5分钟后,加入2-3ml盐酸,滴定过量的,以淀粉试液为指示剂。每mL 0.1mol/L液相当于6.009mg KHSO3。

毒性

亚硫酸氢钾的安全摄入每日允许平(ADI)为0~0.7(SO2计,包括SO2和亚硫酸盐的总ADI值;FAO/WHO,2001)。美国食品药品监督管理局(FDA)将其归类为一般认为安全(GRAS),但不得用于肉类及维生素B1来源的食物。

用途

亚硫酸氢钾常作为分析试剂和还原剂使用,同时也应用于制药工业中。

生产方法

制备方法如下:

[ \mathrm{K_2CO_3 + 2SO_2 + H_2O → 2KHSO_3 + CO_2} ]

向冷的碳酸饱和溶液中通入二氧化硫,直至不再产生二氧化碳且溶液呈酸性为止。操作过程中应充分冷却并注意隔绝空气。

在上述操作中制得的浓溶液中加入等量乙醇,即可析出大量亚硫酸氢钾结晶。抽滤并用乙醇洗涤结晶,在氮气流中进行干燥。

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: K: MVol.3, 5.1.1, page 702 - 708
    摘要:
    DOI:
  • 作为产物:
    描述:
    二氧化硫potassium sulfite 作用下, 以 not given 为溶剂, 生成 potassium bisulfite
    参考文献:
    名称:
    Schuetz, E., Wohlgemuth, L. M.:Die Darstellung von Bisulfiten und Sulfiten in: Monographien ueber chemisch-technische Fabrikationsmethoden, Halle a.d.S. 1911, vol. 23,p. 46
    摘要:
    DOI:
  • 作为试剂:
    描述:
    2-amino-5-(dimethylamino)benzamidepotassium bisulfite 作用下, 以 N,N-二甲基乙酰胺 为溶剂, 反应 30.0h, 以75%的产率得到(E)-6-(dimethylamino)-2-(4-(4-(diphenylamino)styryl)pyridin-2-yl)quinazoline-4(3H)-one
    参考文献:
    名称:
    一种内质网定位成像/光诱导铁死亡双功能探针
    摘要:
    本发明公开了一种内质网定位成像/光诱导铁死亡双功能探针,其制备方法为加入一定量的含喹唑啉酮‑吡啶结构的配体在非极性溶剂中,加入相应的硼化物,用三乙胺调节反应液至碱性,回流反应后,冷却,静置,分层,萃取,有机相用浓缩后得到的混合物,通过柱层析色谱分离,最后得到纯品。该探针结构主要是以喹唑啉酮‑BF2结构为核心结构,以三苯胺、咔唑或其衍生物为修饰基团,具有细胞器成像功能,并在可见光诱导条件下能够诱发肿瘤细胞铁死亡。本发明是第一例内质网定位成像/光诱导铁死亡双功能探针,最大的特点在于该类探针可对活细胞进行实时监测,并能够通过光诱导及成像实现定点诱导肿瘤细胞铁死亡,达到成像指导治疗的目的。
    公开号:
    CN113583031B
点击查看最新优质反应信息

文献信息

  • Phosphinic acid derivatives with metallopeptidase inhibitory activity
    申请人:Zambon Group S.p.A.
    公开号:US05739123A1
    公开(公告)日:1998-04-14
    Compounds of formula (I), ##STR1## wherein R is a biphenyl group optionally substituted, by one or more substituents, the same or different selected among halogen atoms, hydroxy groups, alkoxy, alkyl thioalkyl or alkoxycarbonyl groups having from 1 to 6 carbon atoms in the alkyl moiety, C.sub.1 -C.sub.3 alkyl groups containing one or more fluorine atoms, carboxy groups, nitro groups, amino or aminocarbonyl groups, acylamino groups, aminosulphonyl groups, momo- or di-alkylamino groups having from 1 to 6 carbon atoms in the alkyl moiety, mono- or di-alkylamino-carbonyl groups having from 1 to 6 carbon atoms in the alkyl moiety; R.sub.1 is a hydrogen atom, a straight or branched C.sub.1 -C.sub.6 alkyl group or an arylalkyl group having from 1 to 6 carbon atoms in the alkyl moiety wherein the aryl is a phenyl, a biphenyl, a napthyl or a 5 or 6 membered aromatic heterocycle with one or two heteroatoms selected among nitrogen, oxygen and sulphur, optionally substituted with one or more substituents, the same or different, selected among halogen atoms, hydroxy groups, alkoxy, alkyl, thioalkyl or alkoxycarbonyl groups having from 1 to 6 carbon atoms in the alkyl moiety, C.sub.1 -C.sub.3 alkyl groups containing one or more fluorine atoms, carboxy groups, nitro groups, amino or aminocarbonyl groups, acylamino groups, aminosulphonyl groups, mono- or di-alkylamino groups having from 1 to 6 carbon atoms in the alkyl moiety, mono- or di-alkylaminocarbonyl groups having from 1 to 6 carbon atoms in the alkyl moiety; R.sub.2 is a straight or branched C.sub.1 -C.sub.6 alkyl group, optionally containing one or more fluorine atoms or one or more --NH-- groups, an arylalkyl, an arylcarbonylaminoalkyl, an arylalkylcarbonylaminoalkyl or an arylaminocarbonylalkyl group having from 1 to 6 carbon atoms and optionally one or more --NH-- groups in the alkyl moiety, the aryl being optionally substituted by one or more substituents, the same or different, selected among halogen atoms, hydroxy groups, alkoxy, alkyl, thioalkyl or alkoxycarbonyl groups having from 1 to 6 carbon atoms in the alkyl moiety, C.sub.1 -C.sub.3 alkyl groups containing one or more fluorine atoms, carboxy groups, nitro groups, amino or aminocarbonyl groups, acylamino groups, aminosulphonyl groups, mono-or di-alkylamino groups having from 1 to 6 carbon atoms in the alkyl moiety, mono- or di-alkylaminocarbonyl groups having from 1 to 6 carbon atoms in the alkyl moiety; m is 0 or 1; X is a hydrogen or fluorine atom; the carbon atom marked with an asterisk is an asymmetric carbon atom; and their pharmaceutically acceptable salts, are described. The compounds of formula (I) are endowed with a mixed ACE-inhibitory and NEP-inhibitory activity and are useful in the treatment of cardiovascular diseases.
    公式(I)的化合物,其中R是一个二苯基团,可选择地被一个或多个取代基取代,这些取代基可以是相同的或不同的,包括卤素原子、羟基、烷氧基、烷基或烷氧羰基基团,在烷基部分含有1到6个碳原子,含有一个或多个原子的C.sub.1 -C.sub.3烷基基团,羧基、硝基、基或基羰基基团、酰基基团、基磺酰基团、含有1到6个碳原子的烷基部分的单烷基或双烷基基基团,含有1到6个碳原子的烷基部分的单烷基或双烷基基羰基基团;R.sub.1是氢原子、直链或支链的C.sub.1 -C.sub.6烷基基团或含有1到6个碳原子的芳基烷基基团,其中芳基是苯基、二苯基、基或含有氮、氧和等一到两个杂原子的5或6元芳杂环,可选择地被一个或多个取代基取代,这些取代基可以是相同的或不同的,包括卤素原子、羟基、烷氧基、烷基、基或烷氧羰基基团,在烷基部分含有1到6个碳原子,含有一个或多个原子的C.sub.1 -C.sub.3烷基基团,羧基、硝基、基或基羰基基团、酰基基团、基磺酰基团、含有1到6个碳原子的烷基部分的单烷基或双烷基基基团,含有1到6个碳原子的烷基部分的单烷基或双烷基基羰基基团;R.sub.2是直链或支链的C.sub.1 -C.sub.6烷基基团,可选择地含有一个或多个原子或一个或多个--NH--基团,芳基烷基、芳基羰基基烷基、芳基烷基羰基基烷基或芳基基羰基烷基基团,含有1到6个碳原子并可选择地含有一个或多个--NH--基团,在烷基部分,芳基可选择地被一个或多个取代基取代,这些取代基可以是相同的或不同的,包括卤素原子、羟基、烷氧基、烷基、基或烷氧羰基基团,在烷基部分含有1到6个碳原子,含有一个或多个原子的C.sub.1 -C.sub.3烷基基团,羧基、硝基、基或基羰基基团、酰基基团、基磺酰基团、含有1到6个碳原子的烷基部分的单烷基或双烷基基基团,含有1到6个碳原子的烷基部分的单烷基或双烷基基羰基基团;m为0或1;X为氢或原子;星号标记的碳原子是一个不对称碳原子;以及它们的药用盐。公式(I)的化合物具有混合的ACE抑制和NEP抑制活性,并可用于治疗心血管疾病。
  • Vibrational spectra of group VIII sulphito complexes
    作者:J.P. Hall、W.P. Griffith
    DOI:10.1016/s0020-1693(00)90068-9
    日期:1981.1
    and infrared spectra are reported for Pd(SO 3 )(NH 3 ) 3 and salts containing [Ir(SO 3 ) 2 )Cl 4 ] 5− [Ir(SO 3 ) 2 (NH 3 ) 2 Cl 2 ] 3− , [Rh(SO 3 ) 3 (NH 3 ) 3 ] 3− , [Ir(SO 3 ) 3 (NH 3 ) 3 ] 3− , [Pt(SO 3 ) 4 ] 6− , [Ir(SO 3 ) 4 Cl 2 ] 7− and [OsO 2 (SO 3 ) 4 ] 6− . The results suggests that these contain metal—sulphur bonds and this also appears to be the case for the new complexes Os(SO 3 )(NH 3
    摘要报道了Pd(SO 3)(NH 3)3和含[Ir(SO 3)2)Cl 4] 5− [Ir(SO 3)2(NH 3)2 Cl 2] 3的盐的拉曼光谱和红外光谱。 -,[Rh(SO 3)3(NH 3)3] 3−,[Ir(SO 3)3(NH 3)3] 3−,[Pt(SO 3)4] 6−,[Ir(SO 3) )4 Cl 2] 7-和[OSO 2(SO 3)4] 6-。结果表明它们含有键,对于新的配合物OS(SO 3)(NH 3)4 Cl,[OS(SO 3)3(H 2 O)3] 4−似乎也是如此。和[OS 2 N(SO 3)(NH 3)8(H 2 O)] 3+。所有这些的光谱与已知包含FeO键的[Fe(OSO 2)6] 9-的光谱有很大不同。
  • Phosphorus and potassium fertilizer for all forms of perennial trees, vines and annual crops
    申请人:Alyeshmerni Alfred
    公开号:US20050119124A1
    公开(公告)日:2005-06-02
    Energizing formulations of phosphorous and potassium fertilizer are disclosed that comprise maximally efficient phosphorous pentoxide and di-potassium monoxide combinations. Methods of manufacture and use for these compounds and formulations are also disclosed. The fertilizer formulations comprise both solid and liquid formulations having variable or fixed pH ranges that are acceptable for aerial, foliar, and soil applications, and suitable for all forms of perennial trees, vines and annual crops. The formulations further possess the ability to control pathogenic soil microorganisms through the use of, for example, formulations comprising combinations of monopotassium phosphite, monopotassium phosphate. monopotassium nitrite, monopotassium nitrate, monopotassium sulfite and monopotassium sulfate.
    揭示了含有最大效率五氧化物和二氧化二组合的激活肥料的配方。还公开了这些化合物和配方的制造和使用方法。肥料配方包括固体和液体配方,具有可变或固定的pH范围,适用于空中、叶面和土壤施用,并适用于所有形式的多年生树木、藤蔓和一年生作物。这些配方还具有通过使用含有一氧化磷酸氢磷酸亚硝酸硝酸亚硫酸氢钾硫酸氢钾组合的配方等来控制病原性土壤微生物的能力。
  • Substituted amides
    申请人:Lin S. Linus
    公开号:US20060106071A1
    公开(公告)日:2006-05-18
    Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.
    结构式(I)的新型化合物是大麻素-1(CB1)受体的拮抗剂和/或反向激动剂,可用于治疗、预防和抑制由CB1受体介导的疾病。本发明的化合物可作为中枢作用药物用于治疗精神病、记忆障碍、认知障碍、偏头痛、神经病、神经炎症性疾病(包括多发性硬化症和格林-巴利综合征)、病毒性脑炎、脑血管意外和头部创伤的炎症后遗症、焦虑症、压力、癫痫、帕森病、运动障碍和精神分裂症。这些化合物还可用于治疗物质滥用障碍、肥胖症或进食障碍,以及哮喘、便秘、慢性肠梗阻和肝硬化的治疗。
  • Process for the preparation of hydantoin precursor of phenylalanine
    申请人:Denki Kagaku Kogyo Kabushiki Kaisha
    公开号:US04549028A1
    公开(公告)日:1985-10-22
    A precursor of phenylalanine containing as a major component 5-benzylhydantoin is prepared by reacting, in an aqueous medium, a bisulfite addition salt of phenylacetaldehyde with cyanide and carbonate ions, each being in a molar ratio of equimol or more to said bisulfite addition salt and ammonium ion in a molar ratio of 2 or more to said carbonate ion. The thus prepared precursor of phenylalanine may be converted into phenylalanine by a hydrolysis under a basic or acidic condition.
    含有5-苯乙基异噁唑作为主要成分的苯丙酸前体,通过在介质中将苯乙醛亚硫酸盐与化物和碳酸根离子反应制备而成,其中化物和碳酸根离子的摩尔比与该双亚硫酸盐相等或更多,根离子的摩尔比与碳酸根离子相等或更多。通过在酸性或碱性条件下解,可以将制备好的苯丙酸前体转化为苯丙酸。
查看更多